[go: up one dir, main page]

MX2013011090A - Ensayo de psa y reactivo para el mismo. - Google Patents

Ensayo de psa y reactivo para el mismo.

Info

Publication number
MX2013011090A
MX2013011090A MX2013011090A MX2013011090A MX2013011090A MX 2013011090 A MX2013011090 A MX 2013011090A MX 2013011090 A MX2013011090 A MX 2013011090A MX 2013011090 A MX2013011090 A MX 2013011090A MX 2013011090 A MX2013011090 A MX 2013011090A
Authority
MX
Mexico
Prior art keywords
psa
carriers
assay method
monoclonal antibodies
average grain
Prior art date
Application number
MX2013011090A
Other languages
English (en)
Other versions
MX347002B (es
Inventor
Shinya Nakayama
Yuki Takahashi
Tomo Shimizu
Yasushi Nakamura
Shinichiro Kitahara
Original Assignee
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd filed Critical Sekisui Medical Co Ltd
Publication of MX2013011090A publication Critical patent/MX2013011090A/es
Publication of MX347002B publication Critical patent/MX347002B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/57555—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporciona un método para el ensayo simple y altamente exacto de PSA por una reacción de una etapa que no utiliza portadores que tienen diferentes tamaños de grano promedio. También se proporciona un reactivo para el mismo. El método de ensayo de PSA comprende sensibilizar portadores insolubles que tienen el mismo tamaño de grano promedio dentro de un rango mayor a 0.20 µm pero 0.40 µm o menos utilizando dos tipos de anticuerpos monoclonales anti-PSA que tienen diferentes epítopos que son anticuerpos monoclonales anti-PSA que reaccionarán con tanto PSA libre como PSA-ACT, que es un compuesto de PSA libre y al-antiquimotripsina, y poner en contacto los portadores con una muestra en la presencia de un promotor de agregación.
MX2013011090A 2011-03-28 2012-03-28 Ensayo de psa y reactivo para el mismo. MX347002B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011069161 2011-03-28
PCT/JP2012/058056 WO2012133482A1 (ja) 2011-03-28 2012-03-28 Psaの測定方法及びその試薬

Publications (2)

Publication Number Publication Date
MX2013011090A true MX2013011090A (es) 2013-12-16
MX347002B MX347002B (es) 2017-04-07

Family

ID=46931192

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011090A MX347002B (es) 2011-03-28 2012-03-28 Ensayo de psa y reactivo para el mismo.

Country Status (11)

Country Link
US (2) US20140080143A1 (es)
EP (1) EP2698633B1 (es)
JP (1) JP6110786B2 (es)
KR (1) KR101835918B1 (es)
CN (2) CN105424936B (es)
AU (1) AU2012233635B2 (es)
BR (1) BR112013024686B8 (es)
CA (1) CA2831398C (es)
MX (1) MX347002B (es)
MY (1) MY165647A (es)
WO (1) WO2012133482A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799874A4 (en) * 2011-12-28 2015-08-12 Sekisui Medical Co Ltd LATEX PARTICLES FOR MEASURING PARTICLE AGGLOMERATION
WO2014051144A1 (ja) * 2012-09-28 2014-04-03 積水メディカル株式会社 免疫学的検出方法および免疫学的検出試薬
CN105640991A (zh) * 2016-01-06 2016-06-08 奥思达干细胞有限公司 一种治疗前列腺癌的car-t细胞制剂及其制备方法
EP3574324A2 (en) 2017-01-27 2019-12-04 Roche Diagnostics GmbH Methods for modulating signal intensity in interaction assays
IL272954B2 (en) * 2017-09-19 2024-06-01 Regeneron Pharma Methods of reducing particle formation and compositions formed thereby
CN108802392A (zh) * 2018-08-29 2018-11-13 上海市东方医院 一种用于诊断前列腺癌的层析试纸条及其制备方法和应用
KR102800973B1 (ko) * 2018-10-09 2025-04-29 세키스이 메디칼 가부시키가이샤 류신 리치 α2 글리코 단백질의 면역 측정 방법 및 측정 시약
TWI842764B (zh) * 2018-11-09 2024-05-21 日商積水醫療股份有限公司 抑制以自動分析裝置進行的免疫測定中之異常檢測的方法、檢測方法、免疫測定試劑、及免疫測定試劑套組
JP7355140B2 (ja) 2022-02-28 2023-10-03 住友ベークライト株式会社 セリンプロテアーゼの検出用または測定用試薬
CN117192134A (zh) * 2023-09-14 2023-12-08 宁波美康盛德生物科技有限公司 一种氧化型低密度脂蛋白的检测试剂盒、检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
US5185264A (en) * 1990-11-09 1993-02-09 Abbott Laboratories Diluent buffer and method for diluting an assay component
EP0789032A2 (en) * 1996-02-01 1997-08-13 Bayer Corporation Method for preparing a monoclonal antibody that provides an equimolar response to free and complexed analyte in a monoclonal/polyclonal sandwich immunoassay
JP3652029B2 (ja) * 1996-10-16 2005-05-25 積水化学工業株式会社 高感度免疫測定法
JP2001108681A (ja) 1999-10-07 2001-04-20 Sysmex Corp 免疫凝集測定用試薬及び測定方法
JP4577747B2 (ja) * 2001-06-05 2010-11-10 和光純薬工業株式会社 免疫学的測定法用凝集促進剤
ATE465409T1 (de) 2001-07-02 2010-05-15 Sekisui Medical Co Ltd Latex-trägerpartikel für ein testreagenz, und testreagenz
JP4241301B2 (ja) * 2003-09-30 2009-03-18 和光純薬工業株式会社 免疫学的測定用試薬
US20080044926A1 (en) 2004-12-24 2008-02-21 Daiichi Pure Chemicals Co., Reagent for Assaying Antigen and Method of Assaying Antigen
CN102565397B (zh) * 2005-12-07 2015-07-08 积水医疗株式会社 防止血清干扰及提高抗磷脂抗体测定剂保存稳定性的方法
JP2007163319A (ja) * 2005-12-14 2007-06-28 Sanyo Chem Ind Ltd 免疫測定法及び免疫測定用試薬キット
EP1970704B1 (en) 2005-12-28 2016-07-13 Sekisui Medical Co., Ltd. Reagent for measuring aggregation and method of measuring aggregation
KR101433974B1 (ko) * 2006-07-24 2014-08-25 세키스이 메디칼 가부시키가이샤 응집 저해 측정법 및 응집 저해 측정용 시약
WO2009107398A1 (ja) * 2008-02-29 2009-09-03 積水メディカル株式会社 高分子量アディポネクチンの測定方法
EP2295969B1 (en) 2008-07-04 2016-05-18 Sekisui Medical Co., Ltd. Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement
CN102227639B (zh) * 2008-12-04 2015-12-02 积水医疗株式会社 人体液中的半胱氨酸蛋白酶抑制剂c的测定方法
EP2799874A4 (en) * 2011-12-28 2015-08-12 Sekisui Medical Co Ltd LATEX PARTICLES FOR MEASURING PARTICLE AGGLOMERATION
US9465033B2 (en) * 2012-03-30 2016-10-11 Sekisui Medical Co., Ltd. Latex particles for agglutination assay
JP5566557B1 (ja) * 2012-09-27 2014-08-06 積水メディカル株式会社 粒子凝集測定用ラテックス粒子

Also Published As

Publication number Publication date
CN105424936B (zh) 2018-09-21
EP2698633A1 (en) 2014-02-19
EP2698633B1 (en) 2017-10-11
KR20140015488A (ko) 2014-02-06
US20160011181A1 (en) 2016-01-14
KR101835918B1 (ko) 2018-03-07
JP6110786B2 (ja) 2017-04-05
CA2831398C (en) 2020-06-09
WO2012133482A1 (ja) 2012-10-04
US20140080143A1 (en) 2014-03-20
AU2012233635A1 (en) 2013-10-17
JPWO2012133482A1 (ja) 2014-07-28
AU2012233635B2 (en) 2016-09-08
BR112013024686B1 (pt) 2020-12-29
MY165647A (en) 2018-04-18
MX347002B (es) 2017-04-07
BR112013024686B8 (pt) 2022-05-03
BR112013024686A2 (pt) 2016-12-20
CN103443628A (zh) 2013-12-11
EP2698633A4 (en) 2014-12-17
US10119963B2 (en) 2018-11-06
CN105424936A (zh) 2016-03-23
CA2831398A1 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
MX2013011090A (es) Ensayo de psa y reactivo para el mismo.
MX2016005834A (es) Ensayos para igfbp7 con mejor rendimiento en muestras biológicas.
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
MX350074B (es) Tecnicas para predecir, detectar, y reducir la interferencia de proteinas no especificas en ensayos que implican dominios variables individuales de inmunoglobulina.
WO2013096822A3 (en) Test device for optical and electrochemical assays
CR20110559A (es) Anticuerpos específicos para cadherina-17
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
WO2013052505A3 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
EP2602619A4 (en) IMMUNOCHROMATOGRAPHIC REAGENT COMPOSITION AND MEASURING METHOD USING THE SAME
MX347964B (es) Metodos y kits para la deteccion de células tumorales circulantes en pacientes pancreáticos por medio del uso de captura poliespecífica y reactivos de detección de cocteles.
EP2554990A4 (en) METHOD OF MEASURING USING IMMUNOCHROMATOGRAPHY, TEST BAND FOR IMMUNOCHROMATOGRAPHY AND KIT OF MEASUREMENT REAGENTS FOR IMMUNOCHROMATOGRAPHY
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
GB201207297D0 (en) Analytical methods and arrays for use in the same
MX358772B (es) Metodo para detectar cancer.
MX2016001573A (es) Ensayos para timp2 con mejor rendimiento en muestras biológicas.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
BR112012019475A8 (pt) uso de um anticorpo monoclonal anti-cd44, anticorpo monoclonal anti-cd44, anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra
EP2413144A3 (en) Reagent and kit for assaying D-Dimer
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
WO2013044187A3 (en) Detecting ovarian cancer
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
RU2012148244A (ru) Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
MX2015004419A (es) Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables.

Legal Events

Date Code Title Description
FG Grant or registration